Hubert A - Search Results

1

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.

Kaufman B, Shapira-Frommer R, Schmutzler RK, Audeh MW, Friedlander M, Balmaña J, Mitchell G, Fried G, Stemmer SM, Hubert A, Rosengarten O, Steiner M, Loman N, Bowen K, Fielding A, Domchek SM. Kaufman B, et al. Among authors: hubert a. J Clin Oncol. 2015 Jan 20;33(3):244-50. doi: 10.1200/JCO.2014.56.2728. Epub 2014 Nov 3. J Clin Oncol. 2015. PMID: 25366685 Free PMC article. Clinical Trial.

2

Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiers.

Kaduri L, Gibs M, Hubert A, Sagi M, Heching N, Lerer I, Uziely B, Weinberg N, Abeliovich D, Peretz T. Kaduri L, et al. Among authors: hubert a. Eur J Obstet Gynecol Reprod Biol. 1999 Jul;85(1):75-80. doi: 10.1016/s0301-2115(98)00286-3. Eur J Obstet Gynecol Reprod Biol. 1999. PMID: 10428326

3

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.

Kadouri L, Easton DF, Edwards S, Hubert A, Kote-Jarai Z, Glaser B, Durocher F, Abeliovich D, Peretz T, Eeles RA. Kadouri L, et al. Among authors: hubert a. Br J Cancer. 2001 Jul 6;85(1):36-40. doi: 10.1054/bjoc.2001.1777. Br J Cancer. 2001. PMID: 11437399 Free PMC article.

4

Phase I study of doxil-cisplatin combination chemotherapy in patients with advanced malignancies.

Lyass O, Hubert A, Gabizon AA. Lyass O, et al. Among authors: hubert a. Clin Cancer Res. 2001 Oct;7(10):3040-6. Clin Cancer Res. 2001. PMID: 11595693 Clinical Trial.

5

Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers.

Kadouri L, Kote-Jarai Z, Easton DF, Hubert A, Hamoudi R, Glaser B, Abeliovich D, Peretz T, Eeles RA. Kadouri L, et al. Among authors: hubert a. Int J Cancer. 2004 Jan 20;108(3):399-403. doi: 10.1002/ijc.11531. Int J Cancer. 2004. PMID: 14648706

6

Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers.

Kadouri L, Kote-Jarai Z, Hubert A, Baras M, Abeliovich D, Hamburger T, Peretz T, Eeles RA. Kadouri L, et al. Among authors: hubert a. Br J Cancer. 2008 Jun 17;98(12):2006-10. doi: 10.1038/sj.bjc.6604394. Epub 2008 May 27. Br J Cancer. 2008. PMID: 18542066 Free PMC article.

7

Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer.

Hubert A, Mali B, Hamburger T, Rottenberg Y, Uziely B, Peretz T, Kadouri L. Hubert A, et al. Fam Cancer. 2009;8(3):173-7. doi: 10.1007/s10689-008-9223-7. Epub 2008 Nov 19. Fam Cancer. 2009. PMID: 19016350

8

Mitomycin C and vinblastine: an active regimen in previously treated breast cancer patients.

Ospovat I, Siegelmann-Danieli N, Grenader T, Hubert A, Hamburger T, Peretz T. Ospovat I, et al. Among authors: hubert a. Tumori. 2009 Nov-Dec;95(6):683-6. doi: 10.1177/030089160909500607. Tumori. 2009. PMID: 20210229

9

Preoperative radiotherapy and concurrent chemotherapy with bolus 5-fluorouracil for rectal cancer: a prospective analysis of 98 patients.

Wygoda M, Rottenberg Y, Kadouri L, Pikarsky A, Hubert A. Wygoda M, et al. Among authors: hubert a. Tumori. 2010 Sep-Oct;96(5):709-12. doi: 10.1177/030089161009600512. Tumori. 2010. PMID: 21302617 Clinical Trial.

10

Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy.

Sonnenblick A, Kadouri L, Appelbaum L, Peretz T, Sagi M, Goldberg Y, Hubert A. Sonnenblick A, et al. Among authors: hubert a. Cancer Biol Ther. 2011 Aug 1;12(3):165-8. doi: 10.4161/cbt.12.3.16292. Epub 2011 Aug 1. Cancer Biol Ther. 2011. PMID: 21613821 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters